Evidence map›Paper›PMID 22231558›Full record

ArticleNature medicine2012

A tumor suppressor function of Smurf2 associated with controlling chromatin landscape and genome stability through RNF20.

Michael Blank, Yi Tang, Motozo Yamashita, Sandra S Burkett, Steven Y Cheng, Ying E Zhang

Abstract read
In one paragraph

Article in Nature medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed
6.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 152 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. International journal of molecular sciences · 2026
    Article
  5. SMURF2 in Anticancer Therapy: Dual Role in Carcinogenesis and Theranostics.International journal of molecular sciences · 2026
    Review
  6. International journal of biological sciences · 2026
    Article
  7. Decoding RNF20: an epigenetic modifier and beyond.Frontiers in cell and developmental biology · 2026
    Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Michael BlankLaboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
Yi Tang
Motozo Yamashita
Sandra S Burkett
Steven Y Cheng
Ying E Zhang
Center for Cancer Research · USNational Cancer Institute · USNanjing Medical University · CN

Funding

Physiological and pathological functions of E3 ubiquitin ligases SmurfsZIABC011168 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI ZHANG, YING E · 2009 to 2025
$14.9M
Intramural NIH HHS ZIA BC011168
6 · The paper itself

Abstract

In addition to allelic mutations, cancers are known to harbor alterations in their chromatin landscape. Here we show that genomic ablation of Smad ubiquitin regulatory factor 2 (Smurf2), a HECT-domain E3 ubiquitin ligase, results in dysregulation of both the DNA damage response and genomic stability, culminating in increased susceptibility to various types of cancers in aged mice. We show that Smurf2 regulates the monoubiquitination of histone H2B as well as the trimethylation of histone H3 at Lys4 and Lys79 by targeting ring finger protein 20 (RNF20) for proteasomal degradation in both mouse and human cells. We also show that Smurf2 and RNF20 are colocalized at the γ-H2AX foci of double-stranded DNA breaks in the nucleus. Thus, Smurf2 has a tumor suppression function that normally maintains genomic stability by controlling the epigenetic landscape of histone modifications through RNF20.

Indexed as

AnimalsChromatinDNA Breaks, Double-StrandedDNA DamageDNA MethylationDNA RepairGenes, Tumor SuppressorHistonesHumansMiceMice, Inbred C57BLNeoplasmsUbiquitinationUbiquitin-Protein LigasesChromatinHistonesRNF20 protein, humanSMURF2 protein, humanUbiquitin-Protein Ligases

Identifiers

PMID22231558
PMCPMC3274650
OpenAlexW2126840542

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.